InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Receives $250,000 Grant to Enhance TCB008 Manufacturing Efficiency
TC BioPharm (NASDAQ: TCBP) has secured a $250,000 non-dilutive grant from ScaleReady's G-Rex Program to advance the manufacturing of its TCB008 gamma-delta T cell therapy. The funding will support 18 months of process optimizations aimed at significantly boosting yield and reducing costs by over 80%, targeting large-scale yield improvements by mid-2025, a year ahead of schedule. The grant also provides TC BioPharm access to ScaleReady’s…